ANOS1 rs121912445: Understanding X-Linked Kallmann Syndrome
The rs121912445 variant is a rare genetic change located in the ANOS1 gene, which is associated with X-linked Kallmann syndrome. This condition is characterized by hypogonadotropic hypogonadism, which involves delayed or absent puberty and a reduced or absent sense of smell.
What each genotype means
Typical ANOS1 sequence
This genotype represents the common, non-variant sequence for this location in the ANOS1 gene. It is not associated with the pathogenic changes linked to X-linked Kallmann syndrome.
This is the most common genotype found in the general population.
Potential pathogenic carrier
This genotype indicates the presence of a variant allele on one X chromosome, which is associated with X-linked Kallmann syndrome. Because this condition is X-linked, female carriers are typically asymptomatic but may pass the variant to their children.
This genotype is extremely rare in the general population.
Pathogenic variant present
This genotype indicates the presence of the variant on both X chromosomes in females or the single X chromosome in males. This variant is linked to X-linked Kallmann syndrome, which involves hypogonadotropic hypogonadism and potential issues with sense of smell. Please consult with a medical geneticist or healthcare provider to discuss these findings in the context of your personal health history.
This genotype is extremely rare in the general population.
What is the rs121912445 Variant?
The rs121912445 variant is a specific change in the DNA sequence of the ANOS1 gene, also historically known as KAL1. This gene is located on the X chromosome at position Xp22.3. In genetics, a variant like rs121912445 represents a single point in the genetic code where the nucleotide sequence differs from the most common version found in the general population. Because this variant is located on the X chromosome, it follows an X-linked inheritance pattern. This means that the clinical impact of the variant is typically observed in males, who have only one X chromosome, while females, who have two, may be carriers. This specific variant is classified as a missense mutation, meaning it results in the substitution of one amino acid for another in the protein produced by the gene, potentially altering the protein's structure and function.
The Role of the ANOS1 Gene
The ANOS1 gene provides instructions for making a protein called anosmin-1. This protein is an extracellular matrix molecule that plays a fundamental role in the development of the nervous system. Specifically, anosmin-1 is essential for the migration of olfactory neurons and gonadotropin-releasing hormone (GnRH) neurons during embryonic development. These neurons must travel from the nasal region to the hypothalamus in the brain to function correctly. When the ANOS1 gene is mutated, the production or function of anosmin-1 is impaired, which disrupts the migration of these critical neurons. This disruption prevents the hypothalamus from releasing the hormones necessary to trigger puberty, leading to hypogonadotropic hypogonadism. Additionally, because the olfactory neurons fail to reach their destination, individuals often experience anosmia or hyposmia, which is the loss or reduction of the sense of smell.
Research and Clinical Associations
Research has established that mutations in the ANOS1 gene are responsible for approximately 8% of all cases of Kallmann syndrome. The clinical presentation associated with these mutations is often referred to as X-linked Kallmann syndrome type 1. Beyond the hallmark symptoms of delayed puberty and olfactory dysfunction, clinical literature has documented a range of other potential manifestations in individuals with pathogenic ANOS1 variants. These can include cryptorchidism, micropenis, reduced libido, erectile dysfunction, infertility, unilateral renal agenesis, and synkinesia. It is important to note that while these associations are well-documented in clinical case studies, the severity and specific combination of symptoms can vary significantly between individuals, even those with the same genetic variant. Genetic testing is the primary method used by clinicians to identify these specific mutations in patients presenting with symptoms of congenital hypogonadotropic hypogonadism.
Population Frequency and Interpretation
The rs121912445 variant is considered extremely rare in the general population, as indicated by data from large-scale genomic databases like gnomAD. Because it is a rare, pathogenic variant associated with a specific clinical syndrome, it is not typically found in the general population at high frequencies. For individuals who receive a report of this variant, it is essential to understand that this information is for educational purposes and does not constitute a medical diagnosis. Genetic findings should always be interpreted by a qualified healthcare professional, such as a medical geneticist or an endocrinologist, who can correlate the genetic data with clinical symptoms and family history. If you have concerns about your health or reproductive development, please consult with a clinician to discuss appropriate testing, management, and potential treatment options.
How common is this variant?
The rs121912445 variant is extremely rare in the general population according to gnomAD data.
Frequently asked questions
What is Kallmann syndrome?
Kallmann syndrome is a genetic condition characterized by the combination of hypogonadotropic hypogonadism, which causes delayed or absent puberty, and a reduced or absent sense of smell.
Is rs121912445 the only cause of Kallmann syndrome?
No, Kallmann syndrome is genetically heterogeneous, meaning it can be caused by mutations in several different genes, including FGFR1, CHD7, and others, in addition to ANOS1.
Can women be affected by this variant?
Because ANOS1 mutations are X-linked, females are typically carriers and often do not show the full clinical features of the syndrome, though they can pass the variant to their children.
What should I do if I have this variant?
If you have been identified as a carrier or have this variant, you should consult with a medical geneticist or an endocrinologist to discuss the clinical implications and any necessary health monitoring.
Sources & further reading
Educational information only, last refreshed 10/17/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs121912445?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29